
AZN vs GSK
$AZN vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AZN vs GSK: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·GSK is the weaker of the two on trend, below both its 50- and 200-day averages, while AZN has held above one of them.
- ·Neither kept up with the market over the past year: AZN -1.8% and GSK +3.5%, against the S&P 500 at +8.8%.
- ·The last month has flipped the order: AZN leads over the month (+3.7% against -4.1%) even though GSK leads over the year.
- ·AZN has support 3.2% below at $169.35; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
AZN vs GSK: the quick read
- ·AZN is the larger company by market cap ($277.24B vs $98.26B).
- ·GSK has been more active on our scanner (74 vs 66 alerts in 30 days).
- ·AZN has the smaller float (1.55B vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 74 and 66 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
Objective differences only. Not investment advice.
Watching AZN or GSK? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AZN and GSK on TheDesperateTrader.
- Is AZN or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. AZN is the larger company by market cap ($277.24B vs $98.26B). GSK has been more active on our scanner (74 vs 66 alerts in 30 days). AZN has the smaller float (1.55B vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AZN and GSK?
- The differences that matter: they are similar in size ($277.24B vs $98.26B); they trade at very different share prices ($174.89 vs $47.74); AZN sits at 70% of its 52-week range against 12% for GSK; our scanner flagged AZN 66 times in the last 30 days against 74 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of AZN and GSK is more active right now?
- Right now AZN is at about 0.9x its normal volume and GSK is at about 0.5x, so AZN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is AZN or GSK in the stronger trend?
- AZN is above its 50-day average of $170.42 and below its 200-day average of $180.05; GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31. AZN leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AZN or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.